Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

glaxosmithkline biologicals s.a. - human papillomavirus type 16 l1 protein, human papillomavirus type 18 l1 protein - suspension for injection - 20mcg/dose+ 20mcg/dose

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

glaxosmithkline biologicals s.a. - human papillomavirus type 16 l1 protein, human papillomavirus type 18 l1 protein - suspension for injection - 20mcg/dose+ 20mcg/dose

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - hpv-16 l1; hpv-18 l1 - injection, suspension - 20 μg/0.5ml - hpv-16 l1 20 μg/0.5ml; hpv-18 l1 20μg/0.5ml

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - hpv-16 l20 mcg/0.5ml dose - injection, suspension - 20 mcg/0.5ml dose

European Union - English - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - human papillomavirus1 type 16 l1 protein, human papillomavirus type 18 l1 protein - papillomavirus infections; uterine cervical dysplasia; immunization - vaccines - cervarix is a vaccine for use from the age of 9 years for the prevention of premalignant ano-genital lesions (cervical, vulvar, vaginal and anal) and cervical and anal cancers causally related to certain oncogenic human papillomavirus (hpv) types. see sections 4.4 and 5.1 for important information on the data that support this indication.the use of cervarix should be in accordance with official recommendations.

Canada - English - Health Canada

glaxosmithkline inc - recombinant human papillomavirus type 16 l1 protein; recombinant human papillomavirus type 18 l1 protein - suspension - 20mcg; 20mcg - recombinant human papillomavirus type 16 l1 protein 20mcg; recombinant human papillomavirus type 18 l1 protein 20mcg - vaccines

Kenya - English - Pharmacy and Poisons Board

recombinant hpv16 l1 protein and recombinant… - injection - recombinant hpv16 l1 protein and recombinant… - papillomavirus (human types 16 18)

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - hpv-16 l1; hpv-18 l1 - suspension for injection - hpv-18 l1 20 mcg / 0.5 ml; hpv-16 l1 20 mcg / 0.5 ml - bacterial and viral vaccines, combined - cervarix is a vaccine for use from the age of 9 years for the prevention of premalignant genital (cervical, vulvar and vaginal) lesions and cervical cancer causally related to certain oncogenic human papillomavirus (hpv) types.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - human papillomavirus type 18 l1 protein; human papillomavirus type 16 l1 protein - suspension for injection

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline pharmaceutical sdn. bhd. - hpv type 18 li protein; hpv type 16 li protein -